Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited , a leading manufacturer of targeted, innovative liver cancer therapies, recently announced that during the quarter ending March 2014, dose sales of SIR-Spheres® microspheres grew 25.8 percent in the Americas region compared to the previous corresponding period.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1i7plOl
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1i7plOl
via IFTTT
No comments:
Post a Comment